BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/11/2022 12:11:23 AM | Browse: 306 | Download: 706
Publication Name World Journal of Gastrointestinal Oncology
Manuscript ID 65803
Country/Territory China
Received
2021-03-22 14:24
Peer-Review Started
2021-03-22 14:28
To Make the First Decision
Return for Revision
2021-06-16 02:09
Revised
2021-06-30 06:09
Second Decision
2021-12-06 03:31
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2021-12-08 06:02
Articles in Press
2021-12-08 06:02
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2021-12-31 04:21
Publish the Manuscript Online
2022-01-11 00:11
ISSN 1948-5204 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Minireviews
Article Title Immunotherapy in liver transplantation for hepatocellular carcinoma: Pros and cons
Manuscript Source Invited Manuscript
All Author List Yi Luo, Fei Teng, Hong Fu and Guo-Shan Ding
ORCID
Author(s) ORCID Number
Yi Luo http://orcid.org/0000-0003-1455-4162
Fei Teng http://orcid.org/0000-0001-9076-8862
Hong Fu http://orcid.org/0000-0003-0223-1905
Guo-Shan Ding http://orcid.org/0000-0001-8917-969X
Funding Agency and Grant Number
Funding Agency Grant Number
National Natural Science Foundation of China 81702923
National Natural Science Foundation of China 81871262
Corresponding Author Fei Teng, MD, PhD, Attending Doctor, Surgeon, Surgical Oncologist, Department of Liver Surgery and Organ Transplantation, Changzheng Hospital, Naval Medical University, No. 415 Fengyang Road, Huangpu District, Shanghai 200003, China. tengfei@smmu.edu.cn
Key Words Hepatocellular carcinoma; Liver transplantation; Immunotherapy; Immune checkpoint inhibitors; Adoptive cell transfer; Immunosuppressant
Core Tip This review addresses revolutionized immunotherapy for hepatocellular carcinoma (HCC) in liver transplantation (LT), from downstaging or bridging management in the pretransplant setting to adjuvant or salvage strategy in the posttransplant setting. Considering that the benefit of the antitumor response outweighs the incremental risk of rejection, it is worthwhile to take immunotherapy into account as the salvage option when HCC recurs after LT. More prospective studies are required to provide direct evidence regarding immunosuppressant adjustment, biomarkers for response and the optimal selection of immunotherapy as well as patients.
Publish Date 2022-01-11 00:11
Citation Luo Y, Teng F, Fu H, Ding GS. Immunotherapy in liver transplantation for hepatocellular carcinoma: Pros and cons. World J Gastrointest Oncol 2022; 14(1): 163-180
URL https://www.wjgnet.com/1948-5204/full/v14/i1/163.htm
DOI https://dx.doi.org/10.4251/wjgo.v14.i1.163
Full Article (PDF) WJGO-14-163.pdf
Full Article (Word) WJGO-14-163.docx
Manuscript File 65803_Auto_Edited.docx
Answering Reviewers 65803-Answering reviewers.pdf
Audio Core Tip 65803-Audio core tip.aac
Conflict-of-Interest Disclosure Form 65803-Conflict-of-interest statement.pdf
Copyright License Agreement 65803-Copyright license agreement.pdf
Approved Grant Application Form(s) or Funding Agency Copy of any Approval Document(s) 65803-Grant application form(s).pdf
Non-Native Speakers of English Editing Certificate 65803-Language certificate.pdf
Peer-review Report 65803-Peer-review(s).pdf
Scientific Misconduct Check 65803-Bing-Yan JP-1.jpg
Scientific Misconduct Check 65803-Bing-Gao CC-2.png
Scientific Editor Work List 65803-Scientific editor work list.pdf